PENTABASE A/S

CVR30197852

Core data

Name
PENTABASE A/S
Address
Petersmindevej 1A, 5000, Odense C
Founded
Jan 8, 2007
37 / 27
Locations (P-units)
1View locations
Website
https://pentabase.com/
Facebook
5Base
LinkedIn
pentabase-a-s
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of PENTABASE A/S

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

PentaBase is a Danish, science-driven IVD company developing and producing sensitive and specific PCR assays, diagnostic workflows, and PCR analyses using proprietary INA® DNA analogue technology for oncology and haematology diagnostics.

PentaBase develops and produces innovative PCR solutions and provides genetic analyses and services for precise detection and monitoring of genetic biomarkers, including CE-IVD certified oncology and haematology assays.

Company's own description on virk.dk

PentaBase A/S is a knowledge-driven organization committed to maintaining the highest scientific and ethical standards. We exclusively develop and provide products and services where there is strong clinical evidence supporting the relevance of the underlying biomarkers. Our mission is to advance precision medicine by delivering innovative molecular diagnostic solutions that improve patient stratification, treatment selection, and disease monitoring. Our activities are centered around proprietary DNA technologies and a comprehensive portfolio of molecular diagnostic products supporting the detection, characterization, and monitoring of cancer-related genetic and epigenetic biomarkers. In addition, we collaborate with research institutions, hospitals, and industrial partners by making our proprietary DNA platform technologies available for research and development within molecular diagnostics and life sciences. During 2025, PentaBase continued to strengthen its strategic focus on oncology diagnostics while advancing the commercialization of recently launched technologies and expanding collaborations with international clinical and research partners. Significant efforts have also been dedicated to further developing the Company's proprietary technology platforms and protecting its intellectual property portfolio. Management is satisfied with the Company's development during 2025. The financial performance improved significantly compared with the previous year, reflecting increased commercial activity, continued cost discipline, and a stronger operational foundation for future growth. Management continues to integrate environmental and social responsibility into the Company's decision-making processes. Our facilities include a rooftop solar energy installation, electric vehicle charging stations, and initiatives encouraging sustainable transportation, including cycling and the transition to electric vehicles. Together with customers and suppliers, we continue working to reduce our environmental footprint through improved recycling initiatives and by minimizing the use of plastic and polystyrene packaging materials.

Products & services

Oncology IVD PCR assays · Haematology IVD PCR assays · Custom oligonucleotides · EpiDirect® MGMT Methylation qPCR Assay · MicroSight® MSI · PlentiPlex™ MYD88, CE IVD · EpiDirect® MLH1 · Genetic analyses and services · INA® technology

Industries

Healthcare · Manufacturing

Customer types

Clinical laboratories · Healthcare professionals · Qualified laboratory personnel · Research and clinical labs

Financials

Company financials
Reporting period
2025DKK
Gross profit
10,461,737
Operating profit
-5,712,008
Profit before tax
-1,177,610
Net income
-892,430
Total assets
55,274,233
Equity
53,182,584
Avg. employees
24
2017–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
3696****Show full
bo*****@pentabase.comShow full

From pentabase.com

Main
in**@pentabase.comShow full
Company
+45 36 96 ** **Show full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Anne Gerhart-HinesRoles
Board
TitlesBESTYRELSESMEDLEM
Hans Christian RohdeRoles
Board
TitlesFORMAND
Søren BoeRoles
Board
TitlesBESTYRELSESMEDLEM
Torben Storgaard GuldbergRoles
Board
TitlesBESTYRELSESMEDLEM
Ulf Bech ChristensenRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • ADM. DIR.

Auditor

BDO Statsautoriseret RevisionspartnerselskabAuditorMikkel AalykkeRoleState Authorised Public AccountantFromJun 30, 2026
BDO Statsautoriseret RevisionspartnerselskabAuditor—Role—FromJun 30, 2026
Ownership66.67–89.99 %Voting rights66.67 %FromMar 29, 2020
Ownership5–9.99 %Voting rights0 %FromDec 19, 2025

Child companies

Ownership100 %Voting rights100 %FromJun 5, 2026

Ultimate owners

Ulf Bech Christensen
Ownership through
Unknown stake